Trial Profile
A real world study evaluating treatment persistence with Denosumab and other drugs such as Alendronic-acid, Ibandronic-acid, Raloxifene, Risedronic-acid, Teriparatide, Zoledronic-acid in patients with Osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jul 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid; Ibandronic acid; Ibandronic acid; Raloxifene; Risedronic acid; Teriparatide; Zoledronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 09 Jul 2017 New trial record